Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable Completed Phase Trials for Cytarabine (DB00987)

IndicationStatusPhase
DBCOND0029236 (Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable)CompletedNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01831232Idarubicin, Cytarabine, and Pravastatin Sodium in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic SyndromesTreatment